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Cellular signaling and proliferative action of AVP in mesangium of
SHR: Effect of low density lipoprotein. The present study was undertaken
to determine whether low density lipoprotein (LDL) modulates the
cellular action of arginine vasopressin (AVP) in cultured glomerular
mesangial cells of spontaneously hypertensive rats (SHR) and normoten-
sive Wistar-Kyoto rats (WKY). The AVP-induced cellular signal trans-
duction, including inositol 1,4,5-trisphosphate (1P3) production, fura-2
intracellular calcium measurements and cellular alkalinization, was signif-
icantly greater in cells of SHR than those of WKY. This is based on an
increase in AVP V1 receptor number in cells of the SHR. Also, the AVP
activation of mitogen-activated protein (MAP) kinase and [3H}thymidine
incorporation was significantly exaggerated in cells of SHR compared with
those of WKY. LDL at a concentration of 10 /Lg/ml augmented the
cellular signaling and proliferative action of AVP in cells of WKY, but not
in those of SHR. Since [3H]AVP receptor binding was not affected by the
LDL pretreatment, LDL modulates the signal transduction between a
location distal to the AVP receptors and proximal from the production of
1P3 and diacylglycerol. These results indicate that an increase in AVP
receptor capacity has a profound effect on the AVP-induced cellular
signaling and proliferation, and that LDL has a slight alteration on the
action of AVP in glomerular mesangial cells of SHR.
Arginine vasopressin (AVP) initiates a series of phosphatidyl-
inositol breakdown mediated through V1 receptors in glomerular
mesangial cells [1—31. Its hydrolysis results in an accumulation of
inositol 1,4,5-trisphosphate (1P3) and diacylglycerol, leading to
mobilization of cellular free calcium ([Ca2]i) from endoplasmic
reticulum and stimulation of protein kinase C, respectively [4, 5].
In addition, AVP promotes cellular growth of mesangium, by
activating protein kinase C [6, 7]. AVP activates mitogen-acti-
vated protein (MAP) kinase and induces thymidine incorporation
and c-fos and c-/nyc proteins in glomerular mesangial cells and
homologous cells of the vascular smooth muscle [6-101. There is
increasing evidence to suggest that abnormalities in lipoprotein
metabolism may influence the pathogenesis of cardiovascular
diseases, including the glomeruloscierotic disorder [11]. Both
lipoprotein metabolism and lipoprotein itself have an ability to
exert direct hormonal actions in vascular beds [12, 13]. There are
also low density lipoprotein (LDL) receptors and scavenger
receptors in glomeruli [14]. Recently, we demonstrated that LDL
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augments the cellular signaling and proliferative action of AVP,
and an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A
(ITIMG Co A) reductase conversely diminishes its action in the
cultured rat glomerular mesangial cells [15, 16].
In a homologous cells of vascular smooth muscle, hormonally
activated Na/H exchange is profoundly increased in the cells of
spontaneously hypertensive rats (SHR) as compared to those of
normotensive Wistar-Kyoto rats (WKY) [17, 18]. Such an en-
hanced activation is found with angiotensin II and AVP, and is
mediated via the enhancement of phosphatidylinositol hydrolysis
and [Ca2]i mobilization [19, 20]. The enhancement at least
depends on an increase in the receptor capacity of cells derived
from SHR [21]. However, such an augmentation of the cellular
action of vasoconstrictor hormones has yet to be explored in
glomerular mesangial cells.
The present study was undertaken to determine whether gb-
merular mesangial cells derived from SHR have a distinct char-
acter of responding to the vasoconstrictor hormone AVP versus
those derived from WKY rats. Also, whether or not such an
environmental factor as LDL could modulate the cellular action
of AVP in cultured glomerular mesangial cells of SHR was
examined. This maneuver may clarify if the enhancement by LDL
of the cellular action of AVP could be different between these two
types of cells, because of the genetic background of vascular and
glomerular responsiveness.
Methods
Cell culture
The experimental procedure was similar to that described in
our previous studies [3, 15], modified from the method of
Burlingtron and Cronkite [22] and Scharschmidt and Dunn [23].
Male SHR and WKY (12 weeks old) were used. Kidneys were
removed under sterile conditions, and cortical tissues were cut
away from the medulla. They were minced with 1 ml of physio-
logical saline solution (PSS; 140 m'vi NaCI, 4.6 mM KCI, 1 mM
MgCl,, 2 mivi CaCI2, 10 m glucose and 10 mrvi Hepes, pH 7.4) by
a sharp razor blade. The minced renal cortical tissues were
incubated with 3 ml of collagenase (1 mg/mI; Worthington
Biochemicals, Freehold, NJ, USA) for 60 minutes at 37°C. They
were passed through a series of steel sieves with decreasing pore
sizes (60 and 200 mesh) with the glomeruli appearing on top of
the 200 mesh sieve. The glomeruli were collected into culture
tubes and were centrifuged at 500 g for four minutes at room
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temperature. After aspirating the supernatants, the pellets were
resuspended with Dulbecco's Modified Eagle's Minimal Essential
Medium (DMEM; Flow Laboratories, McLean, VA, USA) sup-
plemented with 20% fetal bovine serum, 100 U/mI penicillin, and
100 sg/ml streptomycin. The dispersed glomeruli were harvested
into 35 x 10-mm plastic dishes with the medium and kept in a
humidified incubator at 37°C under 95% air and 5% CO2.
After the cultured cells were confluent, they were subcultured
using Ca2-free and Mg2 -free Hank's solution containing
0.025% trypsin and 0.01% EDTA. The dispersed cells were
collected into culture tubes and centrifuged at 500 g for four
minutes at room temperature. The pellets were resuspended in
DMEM containing 20% fetal bovine serum, penicillin and strep-
tomycin, and cultured in a humidified incubator. The cultured
cells at the third through tenth passages were subjected to the
following studies on days 7 to 10 of the subculture.
For measurements of [Ca2Ii and cellular pH (pHi), the cells
were cultured on thin glass slides (13 mm in diameter; Matsunami
Kogyo Co., Osaka, Japan). The cultured cells were grown in 35 X
10-mm plastic dishes to study AVP receptor study, 1P3 production
and MAP kinase activity. Also, they were grown on 24-well tissue
culture clusters (Costar, Cambridge, MA, USA) to measure
thymidine incorporation.
A VP receptor binding
The experimental procedure was modified from the method of
Fishman et al [24]. Cells were grown on 35 X 10-mm plastic
dishes. Cells were exposed for 24 hours to the medium containing
10 sg/ml human LDL (Biomedical Technologies, Stoughton, MA,
USA) or the vehicle before the start of experiments. They were
rinsed twice with 2 ml ice-cold binding buffer (119.2 miu NaC1, 3.0
mM KC1, 1.2 m'vi MgSO4, 1.0 mivi CaCI2, 1.2mM KH2PO4, 10 mM
glucose, and 25 mr'i Hepes, as well as 0.1% BSA, pH 7.4) and then
incubated with 1 ml ice-cold binding buffer containing 0.2 to 20 X
i0 M [3HIAVP (sp act 67.6 Ci/mmol; New England Nuclear,
Wilmington, DE, USA) in the presence or absence of 1 X 10 NI
AVP (Sigma, St. Louis, MO, USA) at 4°C for 60 minutes.
Non-specific binding was determined in the presence of 1 X i0
M AVP. The buffer also contained 10 pg/ml LDL which was
similar to that during the preincubation. The control group was
carried out with the vehicle in a similar manner. After the
incubation, the cells were rinsed four times with 2 ml of ice-cold
binding buffer, followed by the addition of 1 ml 0.1 N NaOH
containing 1% sodium dodecylsulfate (SDS). The radioactivity
was counted with a liquid scintillation counter (Model LSC-671;
Aloka, Tokyo, Japan). Protein was measured by the method of
Lowry et al [25].
Measurement of inositol irisphosphate
The experimental procedure was similar to that described in
our previous reports [15, 161. Cells grown on 35 X 10-mm plastic
dishes were used in the present study. The cells were washed twice
with 2 ml of inositol-free DMEM and incubated with 2 ml of
inositol-free DMEM containing 5 jsCi/ml [myo-3H]inositol (sp act
19.1 Ci/mmol; Amersham Tnt., Amersham, Buckinghamshire,
UK) for 24 hours in a humidified incubator. The medium also
contained 10 or 100 ig/ml LDL or the vehicle. At the time of
experiment, the cells were rinsed twice with 2 ml of PSS and then
incubated with 0.8 ml of PSS containing I X i0 and I x 10
M AVP for 10 seconds. The reaction was stopped by the addition
of 0.2 ml 50% trichloroacetic acid, and then the cells were scraped
using disposable plastic chips for Eppendorf. The suspensions
containing the disrupted cells were centrifuged using a microcen-
trifuger. The supernatants were washed five times with ether and
the water-soluble fractions were brought to pH 7.0 using 1 N
NaOH and stored at —20°C until the analysis. The pellets were
dissolved with 1 ml 0.1 N NaOH containing 1% SDS and stored at
4°C for protein assay. The water-soluble fractions were applied to
columns containing 1 ml of Dowex (1-x8, formate form; Muro-
machi Kagaku, Kogyo, Tokyo, Japan) and serially eluted 10 times
with 2-ml aliquots of H20, Borax (5 mM disodium tetraborate, 60
m sodium formate), 0.2, 0.4 and 1.0 M ammonium formate in 0.1
M formic acid. This maneuver separated inositol, glycerophos-
phatidylinositol, inositol-1-phosphate, inositol bisphosphate and
1P3, respectively. 1P3 fraction includes 1,3,4-1P3, 1,4,5-1P3, and
I ,3,4,5-inositol tetrakisphosphate. Samples were collected into
scintillation counter vials and counted using a liquid scintillation
counter.
Measurement of fCa2'7,
The experimental procedure was similar to that used in our
previous reports [26, 27]. The cells were preincubated with the
medium containing 10 jsg/ml LDL for 24 hours and then rinsed
twice with 1 ml PSS. They were loaded with 5 ISM fura-2/AM
(Dojin Biochemicals, Kumamoto, Japan) for 60 minutes at 37°C
in a volume of 0.25 ml PSS containing 10 jig/mI LDL. Control
group of cells were performed with the vehicle in a same manner.
After aspiration of the fura-2/AM solution, the glass slides were
rinsed and then placed in a 1 >< 1-cm quartz cuvette with the aid
of a special holder in a fluorescence spectrophotometer (CAF-
110; Japan Spectroscopic Co., Tokyo, Japan). The dual-wave-
length excitation method for measurement of fura-2 fluorescence
was used. The fluorescence was monitored at 500 nm, with
excitation wavelengths of 340 and 380 nm in the ratio mode. The
effectors of AVP and endothelin-1 (Peptide Institute, Osaka,
Japan) were added after a stable fluorescence signal (R) was
achieved. From the ratio of fluorescence at 340 and 380 nm, the
[Ca2]i was determined as described by Grynkiewicz, Poenie and
Tsien [28], using the following expression:
[Ca2]i (nM) = K, x [(R — Rmin)/(Rm — R)] X
where R is the ratio of fluorescence of the sample at 340 and 380
nm, and Rrnax and were determined as described previously
[26]. The term is the ratio of fluorescence of fura-2 at 380 nm in
zero and saturating Ca2' concentrations. Kd is the dissociation
constant of fura-2 for Ca2', assumed to be 224 nM at 37°C [28].
Measurement of pHi
The experimental procedure was similar to that described
previously [29]. The study was carried out in HCO3-frec buffer
using PSS. The cells were preincubated with the medium contain-
ing 10 jig/mI LDL for 24 hours and then rinsed twice with I ml
PSS. They were loaded with 2 jiM 2',7'-bis-(2-carboxymethyl)5
(and 6)carboxyfluorescein acetoxymethyl ester (BCECF/AM; Mo-
lecular Probes, Inc., Eugene, OR, USA) for 60 minutes at 37°C in
a volume of 0.25 ml PSS containing 10 jig/mI LDL. Control group
of cells was performed with the vehicle in a same manner. The
complete intracellular hydrolysis of BCECF/AM to BCECF was
judged by changes in the excitation and emission spectra. The
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fluorescence was monitored at 530 nm, with excitation wave-
lengths of 450 and 500 rim in the ratio mode. After measurement
of the basal pHi level, AVP was added. The fluorescence signal
was calibrated at several pH values (6.6, 7.0 and 7.4) in the KCI
solution (140 mtvi KCI, 4.6 ms NaCI, 1 msi MgCl2, 2 mx CaCI2, 10
m glucose and 10 mt Hepes) containing the K/H ionophore
nigericin (10 j.g/ml).
MAP kinase assay
The experimental procedure was similar to that used in our
previous studies [15, 16]. Cells grown on 35 x 10-mm plastic
dishes were incubated with serum-free DMEM in the presence or
absence of 10 .tg/ml LDL 24 hours before the start of the
experiments. The cells were rinsed twice with 2 ml of PSS. The
cells were incubated for 10 minutes at 37°C with 1 ml of 1 >< 10
and 1 >< 10 M AVP. Also, the study was performed with 1 x
iO M endothelin-1 and I x i0— M platelet-derived growth
factor (PDGF) BB (Upstate Bioteehonolgy, USA). After aspira-
tion of the effector solutions, the cells were exposed to 0.5 ml of
the solution containing 20 ms'i Tris, 5.6 m'vi /3-glyccrophosphate,
10 mM EGTA, 10 mst MgCl2, 0.1 mi'vi NaF, 2 mivi DTT, 1 mM
NaVO3, 20 rg/ml aprotinin, and 1 mivi PMSF, pH 7.5. Thereafter,
the dishes were immediately put on dry ice. The extracts were
collected into microcentrifuge tubes by disposable plastic chips for
Eppenclorf. After centrifugation, the supernatants were trans-
ferred to plastic tubes and kept at —20°C until the time of assay.
Glass tubes containing 0.06 ml of the assay mixture (40 mrvt Tris,
40 mivi MgCl2, 2.5 mg/mI myelin basic protein [Sigma], 0.5 mii
ATP, and 0.5 .rCi 32P-yATP [sp act >10 Ci/mmol; Amersham])
were incubated at 25°C for 15 minutes. Then 0.04 ml of samples
were added and the mixtures were incubated for an additional 10
minutes at 25°C. The mixtures were transferred onto glassfiber
filters (Whatman 2.4-cm GF/C; Whatman, Maidstone, UK) by
using disposable plastic chips for Eppendorf. The filters were then
put into ice-cold 10% trichloroacetic acid containing 50 mivi
sodium pyrophosphate, and shaken gently for 20 minutes. This
maneuver was repeated four times. The filters were immersed in
ice-cold ethanol for 20 minutes. After the filters were exposed to
diethylether, they were put into counting vials containing 10 ml of
scintillation solution. The radioactivity was counted by using
Aloka liquid scintillation counter. Also, cellular protein of all
samples were measured by the method of Lowry et al [25].
Measurement of thymidine incolporation
The experimental procedure was similar to that described
previously [15, 16]. Cells grown on 24-well tissue culture clusters
were used to assess DNA replication. At confluency, the cells were
synchronized to the quiescent state by incubation in 1 ml of
serum-free DMEM. After 24 hours, cells were exposed to the
varying stimuli which were dissolved in the serum-free DMEM.
The medium contained [3H]thymidine (1 jiCi/well; sp act 80.8
Ci/mmol; New England Nuclear). The stimuli included I x 10—8
to 1 X l0' M AVP and 10 igJml LDL. The cells were incubated
with 1 ml of the effector for an additional 24 hours in the
humidified incubator. Thereafter, the cells were rinsed four times
with PSS and immersed with 0.5 ml of 10% trichloroacetic acid.
They were collected into counting vials by disposable plastic chips
for Eppendorf, and with 10 ml of scintillation solution then added.
The radioactivity was counted by using Aloka liquid scintillation
counter. Cells grown on several wells of 24-well tissue culture
Fig. 1. Scatchard analysis of /3JJJ.4 VP binding to the cultured glomerular
mesangial cells den ved from STIR and WKY. Symbols are: (•) and (0) show
the groups of cells of SHR, pretreated for 24 hours with vehicle and 10
jLg/ml LDL, respectively; (U) and (0) show the groups of cells of WKY,
pretreated for 24 hours with vehicle and 10 .g/ml LDL, respectively.
Values are the means of triplicate determinations obtained in a single
experiment.
cluster were collected and protein contents were measured by the
method of Lowry et al [25].
Statistics
All values of 1P3 production, [Ca2]i, pHi, MAP kinase activity
and [3H]thymidine incorporation were analyzed by an analysis of
multiple variance and Neuman Keuls' range test. P < 0.05 was
considered significant.
Results
Figure 1 shows the Scatchard analysis of [3H]AVP receptor
binding to the cultured glomerular mesangial cells derived from
SHR and WKY. K1 and were 1.39 0.17 >< 10'° M and
3.9 0.2 >< 10° M/mg protein in the cells derived from WKY,
respectively. B,,a of SHR was 10.4 0.6 X 10 M/mg protein,
which was greater than that in the cells from WKY, whereas there
was no difference in Kd values between SHR and WKY (1.33
0.12 X 10°vs. 1.39 0.17 X 10°M).AsshowninFigurel,the
10 jig/mI LDL pretreatment did not affect K1 and values in
both cultured glomerular mesangial cells of SHR and WKY.
Whether or not LDL modulates the AVP-induced increase in
1P3 production in the cultured rat glomerular mesangial cells was
examined. As shown in Figure 2, AVP per se significantly in-
creased 1P3 production in both glomerular mesangial cells of SHR
and WKY. Its production was greater in the cells of SHR than
that in the cells of WKY (1 X 10 M AVP; 1.72 0.04 vs. 2.36
0.09 X I0 CPM/mg protein, P < 0.01). Such an AVP-induced
increase in 1P3 production was significantly enhanced by the
24-hour pre-exposure of cells of WKY to 10 jig/mI LDL(1 X i0
M AVP; 1.72 0.04 vs. 2.19 0.06 X i04 CPM/mg protein, P <
1.0
ci)
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0.01). However, in the cells of SHR the 10 jrg/ml LDL pretreat-
ment did not alter its production. Similar results were obtained
with 100 j.g/ml LDL. The 100 1rtg/ml LDL pretreatment aug-
mented the 1 >< 10 M AVP-induced increase in 1P3 production
in cells of WKY, but not in SHR (data not shown). The basal
levels of 1P3 production remained unchanged in the cells pre-
treated with 10 ig/ml LDL for 24 hours.
Figure 3 depicts the effect of LDL on the AVP-induced increase
in [Ca2Ii in cultured rat glomerular mesangial cells of SHR and
WKY. As shown in the left side, AVP increased [Ca2]i in a
dose-dependent manner. The LDL pretreatment significantly
augmented its mobilization of [Ca2]i (1 X 10 M AVP; 240.9
20.3 vs. 549.8 66.2 nrt, P < 0.01). In glomerular mesangial cells
of SHR, the AVP-induced increase in [Ca2 ]i was greater than
that in the cells of WKY (1 x 10 M AVP; 240.9 20.3 vs.
574.9 76.8 nM, P < 0.01). However, the enhancement by LDL
of AVP mobilization of [Ca2 I ]i was not so evident, though the
1 X 10 M AVP-induced [Ca2]i was significantly higher in cells
pretreatcd with LDL than that in the cells of SHR treated with the
vehicle for LDL.
Also, the enhancement by LDL of the AVP-mobilized [Ca21i
is shown in Figure 4. When cells were preexposed to LDL for 24
hours, the greater response of [Ca2]i to 1 X i0 M AVP was
found with the higher concentration of LDL in both cells of SHR
and WKY. In contrast, the basal levels of [Ca2]i remained
unchanged in the absence and presence of LDL.
Effect of LDL on the AVP-induced alteration in pHi in the
cultured glomerular mesangial cells of SHR and WKY is depicted
in Figure 5. As shown in our previous report [3], AVP caused an
initial cellular acidification in three minutes, followed by a sus-
tained cellular alkalinization in glomerular mesangial cells. The
maximal pHi was obtained about six to eight minutes after the
addition of AVP. The 1 X iO M AVP-induced cellular alkalin-
ization was significantly greater in cells of SHR than that in cells
of WKY (+0.15 0.02 vs. +0.10 0.01, P < 0.05), whereas the
AVP-induced cellular acidification was not different in cells of
SHR and WKY. The 24 hour exposure to 10 pg/ml LDL
significantly augmented the 1 x iO M AVP-induced cellular
alkalinization in cells of WKY (+0.10 0.01 vs. +0.17 0.01,
P < 0.01), but not in cells of SHR. The initial cellular acidification
was not affected by LDL.
Figure 6 shows the AVP-activated MAP kinase in cultured
glomerular mesangial cells derived from SHR and WKY. One X
io— and I X iO M AVP significantly activated MAP kinase, an
activation significantly greater in cells of SHR than that in cells of
WKY (1 X 106 M AVP; 28.7 1.2 vs. 98.6 6.7 pmol/mg
protein, P < 0.01). When cells were pretreated for 24 hours with
10 jig/mI LDL, the AVP-activated MAP kinase was significantly
enhanced in cells of WKY (1 x 10—6 M AVP; 28.7 1.2 vs. 38.7
2.2 pmol/mg protein, P < 0.01), but it was not found in cells
-+—— derived from SHR. The basal activity of MAP kinase was greater
6 in cells of SHR than that in cells of WKY.
We examined whether LDL modulates the AVP-induced
[3H]thymidine incorporation into cultured glomerular mesangial
cells of SHR and WKY (Fig. 7). In both cells derived from SHR
and WKY, the AVP-induced [3Hjthymidine incorporation was
obtained in a dose-dependent manner. Mesangial cells of SHR
had greater [3H]thymidine incorporation than those of WKY (1 X
iO M; 1.47 0.10 vs. 3.39 0.13 X iO CPM/mg protein, P <
0.01). However, the pretreatment with 10 j.Lg/ml LDL did not
affect the AVP-induced [3H]thymidine incorporation in cells of
SHR, whereas its pretreatment significantly enhanced in cells of
WKY.
Lastly, we examined the effect of 10 jig/mI LDL on endothelin-
1-induced increases in [Ca2Ji and MAP kinase in the cultured
glomerular mesangial cells from WKY. One X i0 M endothe-
lin-1 increased [Ca2]i from 92.6 6.8 to 384.6 21.5 nM (N =
6, P < 0.01; Fig. 8). When cells were exposed for 24 hours to 10jig/ml LDL, the 1 X 10 ' M endothelin-1-induced increase in
[Ca2]i was enhanced (384.6 21.5 vs. 557.2 29.1 nrvt, P <
0.01). Also, 1 X iO- M endothelin-1 activated MAP kinase from
13.2 2.1 to 31.8 3.7 pmol/mg protein (N = 4, P < 0.01), that
was augmented by 10 jig/mI LDL (31.8 3.7 vs. 50.1 4.8
pmol/mg protein, P < 0.05; Fig. 9). Similar results were obtained
with PDGF-BB (Fig. 9). One X 10 M PDGF-BB increased
MAP kinase from 11.9 1.8 to 34.1 3.9 pmol/mg protein (P <
0.01), and the pretreatment with 10 jig/ml LDL enhanced the
action of PDGF-BB (34.1 3.9 vs. 48.8 2.7 pmol/mg protein,
P < 0.05).
Discussion
In the present study we confirmed that AVP stimulates the
breakdown of phosphatidylinositol, mediated through V1 recep-
tors, in glomerular mesangial cells derived from SHR and WKY
[1—3]. Such a signal transduction by AVP promoted [Ca2ji
mobilization, resulting in contraction of glomerular mesangial
cells [30]. The early mobilization of [Ca2 ji is derived from both
intra- and extracellular Ca2, and the sustained phase depends to
a great extent on extracellular Ca2 [3]. AVP produced a biphasic
change in pHi, namely, an early cellular acidification, followed by
a sustained cellular alkalinization. We have already reported that
the change in pHi is closely related to that in cellular Na
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Fig. 2. Effect of LDL on the A VP-induced increase in 1P3 production in the
cultured glomerular mesangial cells of WKY (A) and SHR (B). Symbols are:
(S) control group of cells; (0) cellspretreated with 10 ig/ml LDL for 24
hours. *P < 0.01 versus the control group. Values are means SEM, N
6.
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Fig. 3. Effect of LDL on the A VP-induced
increase in [Ca2 Ji in cultured glomerular
mesangial cells derived from WKY (A') and SHR
(B). Symbols are: (•) control group of cells;(0) cells pretreated with 10 pg/mI LDL for 24
hours. < 0.01 versus the control group.
Values are means SEM, N = 6.
concentration, which also depends on cellular second messenger
[Ca2]i [3, 31]. In addition, AVP promoted cellular growth of
mesangium, as AVP activated MAP kinase and stimulated
[3fllthymidine incorporation into the cultured glomerular mesan-
gial cells of SHR and WKY. MAP kinase is serine/threonine-
specific kinase and is downstream of protein kinase C in the
cellular signal transduction pathway of AVP [7, 9, 10].
The present study clearly demonstrated that the cellular action
of AVP was markedly greater in glomerular mesangial cells of
SHR than those of WKY. Their differences were found in all the
steps of signal transduction, including 1P3 production, [Ca2]i
concentration, cellular alkalinization, MAP kinase activation and
[3H]thymidine incorporation. 1P3 production can be indicating the
activity of phospholipase C. As shown in Figure 1, the Bmax of
SHR was 2.7 times greater than that of WKY, whereas the Kd was
similar in both groups of cells. These results therefore indicate
that such a distinct receptor capacity is a causitive factor for the
exaggerated difference in cellular signaling of AVP in glomerular
mesangial cells, derived from SHR and WKY. Similar results were
obtained in a homologous cells of vascular smooth muscle cells
[21]. Kd values were 1.33 X 10_b M and 1.39 X 10_bo M in
mesangial cells from SHR and WKY, respectively, values 3.6 to
3.7 times different from the K of 3.7 >< I 0' M in mesangial cells
of SD rats [15]. We have to recognize the calculation mistake in
the previous paper [15].
In the cultured glomerular mesangial cells of WKY LDL
enhanced the cellular signaling of AVP. LDL augmented the
AVP-induced increase in 1P3 production, without any alteration in
[3HIAVP receptor binding. Therefore, LDL modulates the signal
transduction between distal to the AVP receptors and proximal
from the production of 1P3 and diacylglycerol. The LDL pretreat-
ment did not affect the basal levels of W3 and [Ca2 1i. These
results confirm our previous findings in the cultured rat glomer-
ular mesangial cells showing LDL augments the cellular signaling
of AVP [15]. In an additional study, LDL also enhanced PDGF-
BB-activated MAP kinase in glomerular mesangial cells from
WKY. PDGF-BB has tyrosine kinase receptors, and it links to
Vehicle 0.1 1 10 100
LDL, p.g/mI
Fig. 4. LDL enhances the 1 X io— MA VP-induced increase in [Ca2 Ji in
the cultured glomerular mesangial cells of SHR (•, 0) and WKY ( LI). The
cells were prcincubated for 24 hours with the indicated concentrations of
LDL. (•, •) Basal [Ca2]i, (0, 0) 1 x 10 M AVP-induced [Ca2*Ii.
*P < 0.01 versus the vehicle. Values are means SEM, N = 6.
activation of G protein-coupled phospholipase C [32]. This may
be the reason why LDL enhanced the proliferative action of
PDGF-BB, as well as that of AVP and endothelin-I. A study
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Fig. 5. Effect of LDL on thel X 107 MA VP-
induced changes in cellular pH (pHi) in the
cultured glomendar mesangial cells of SHR and
WKY. The graph shows the minimal and
maximal pHi as pHi. Symbols are: (U) the
control group of cells; () the LDL groups of
cells, prcincubated for 24 hours with 10 sgiml
LDL. < 0.01 versus controls. Values are
means SCM, N = 6.
suggested that the action site of LDL is phosphatidylinositol
bisphosphate-specific phospholipase C [lfl. However, such an
augmentation by LDL was not found in the cultured glomerular
mesangial cells of SHR. The 24 hours exposure of cells to LDL
had no effect on the AVP-induced increase in 1P3 production,
MAP kinase activation, and [3H]thymidine incorporation, as well
as [3H]AVP receptor binding. Scannapieco et al 1331 reported that
the receptor binding of LDL is significantly greater in a homolo-
gous cells of vascular smooth muscle derived from SHR than
those from WKY, but this might not account for the enhancement
by LDL of AVP action in cells of SHR. As mentioned earlier, the
cellular signal transduction of AVP is markedly augmented in
SHR as compared to that of WKY. These results suggest that an
increase in AVP receptor number markedly augments the AVP-
induced cellular signaling and proliferation, and that LDL could
not alter the action of AVP in glomerular mesangial cells derived
from SHR.
There was some discrepancy in the AVP-induced increase in
1P3 production and [Ca2 Ii in glomerular mesangial cells of SHR.
The LDL pretreatment enhanced the AVP-induced increase in
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Fig. 6. Modulation by LDL of the A VP-activated
MAP kinase in the cultured glomerular mesangial
cells of WKY (A) and SHR (B). Symbols are:(U) the control groups of cells; () the LDL
groups of cells, pretreated for 24 hours with 10
sg/ml LDL. *P < 0.01 versus the control.
Values are means SCM, N = 6.
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Fig. 8. A 24 hour exposure to 10 pg/mI LDL enhances the I >< io M
endothelin-1 -induced increase in /Ca2Ji in cultured glomerular mesangial
cells derived from WKY Symbols are: () the basal levels; () the I X lO
M endothelin-1-induced [Ca21i. Values are means SEM, N = 6.
[Ca2]i in Figure 4, hut it was not so evident in Figure 3. Also, the
AVP-induced change in pHi, MAP kinase activation and [3H]thy-
midine incorporation were not altered by LDL in glomerular
mesangial cells of SHR. Since the AVP-induced cellular alkalin-
ization, MAP kinase activity and [3H)thymidine incorporation
depend on a protein kinase C-mediated pathway, the increase in
[Ca2]i may not affect these parameters. The enhanced mobiliza-
tion of AVP-induced [Ca2]i by LDL may contribute to cellular
contraction of SHR mesangium. However, we cannot interpret
the LDL enhancement of [Ca21i increase by AVP in mesangial
cells of SHR. LDL may have other action site to mobilize [Ca2)i
in glomerular mesangial cells derived from SHR. For instance,
LDL may affect extracellular calcium entry in addition to intra-
cellular calcium release. In addition, the basal levels of [Ca2]i
were similar in cells from SHR and WKY, but the basal levels of
MAP kinase and [3Hthymidine incorporation were significantly
higher in SHR than WKY. These differences may also influence
no additive effect of LDL on the AVP-activated MAP kinase and
[3Hlthymidine incorporation in cells from SHR.
Central to the development of atherosclerosis is the involve-
ment of lipid deposition in the wall of arteries, particularly LDL
[34]. Recent works suggest that the oxidation of LDL in vessel
walls is a critical step in the pathogenesis of atherosclerosis [351.
In glomerulus, focal glomerulosclerosis is an analogous condition
of atherosclerosis, and oxidized LDL is involved in the pathogen-
esis of focal glomeruloscierosis [36). The present finding that LDL
augmented the AVP-induced cellular signaling and growth seems
unlikely to he directly related to sclerotic disorder, because the
present study was determined by only a short exposure to LDL,
and the effect of LDL was distinct from that of oxidized LDL [15,
37].
In summary, we demonstrated that cellular signaling of AVP
was markedly enhanced in glomerular mesangial cells of SHR, as
compared to that in WKY. This difference was based on an
increase in AVP receptor capacity in cells of SHR. The LDL
pretreatment augmented the AVP-induced cellular signaling and
proliferation in cells of WKY, but not in cells of SHR. A lack of
the effect of LDL seems likely to be due to the marked partici-
pation of the genetic factor of increased AVP receptor numbers in
glomerular mesangial cells of SHR. The present results indicate
that an increase in AVP receptor capacity has a profound effect on
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Fig. 7. Modulation by LDL of the A VP-induced
increase in [3HJthymidine inco/poration into the
cultured glomerular mesangial cells of WKY (A)
and SHR (B). Symbols are: (S) the control
groups of cells; (0) the LDL groups of cells,
pre-exposed for 24 hours to 10 /.Lg/ml LDL.
*p < 0.01 versus the control. Values are
means SEM, N = 4.
P<0.01
60
50
40
30
C
20
10
0
Fig. 9. Modulation by LDL of the endothelin-1-
and PDGF-BB-activated M4P kinase in cultured
glomerular mesangial cells of WKY. The LDL
groups of cells were pretreated with 10 g/ml
LDL for 24 hours. A. Symbols are: (LI) vehicle
group; () 1 >< i0 M endothelin-1 group. B.
Symbols are: (LI) vehicle group; () 1 X 10
M PDGF-BB group. Values are means SEM,
N = 4.
the AVP-induced cellular signaling and proliferation, and that
LDL has a little alteration on the action of AVP in glomerular
mesangial cells derived from SHR.
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